A detailed history of Integrated Wealth Concepts LLC transactions in Roivant Sciences Ltd. stock. As of the latest transaction made, Integrated Wealth Concepts LLC holds 246,537 shares of ROIV stock, worth $3.13 Million. This represents 0.04% of its overall portfolio holdings.

Number of Shares
246,537
Previous 237,373 3.86%
Holding current value
$3.13 Million
Previous $2.51 Million 13.39%
% of portfolio
0.04%
Previous 0.04%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$10.17 - $12.5 $93,197 - $114,550
9,164 Added 3.86%
246,537 $2.85 Million
Q2 2024

Aug 14, 2024

BUY
$10.36 - $11.74 $504,418 - $571,608
48,689 Added 25.8%
237,373 $2.51 Million
Q1 2024

May 15, 2024

BUY
$9.87 - $11.8 $1.86 Million - $2.23 Million
188,684 New
188,684 $1.99 Million

Others Institutions Holding ROIV

About Roivant Sciences Ltd.


  • Ticker ROIV
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 704,382,976
  • Market Cap $8.95B
  • Description
  • Roivant Sciences Ltd., a biopharmaceutical and healthcare technology company that researches and develops medicines. The company develops product candidates for the treatment of various therapeutics, including solid tumors, sickle cell diseases, hypophosphatasia, oncologic malignancies, psoriasis, atopic dermatitis, vitiligo, hyperhidrosis, acne...
More about ROIV
Track This Portfolio

Track Integrated Wealth Concepts LLC Portfolio

Follow Integrated Wealth Concepts LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Integrated Wealth Concepts LLC, based on Form 13F filings with the SEC.

News

Stay updated on Integrated Wealth Concepts LLC with notifications on news.